{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:57:36Z","timestamp":1792587456914,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3772-9","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T22:36:05Z","timestamp":1511217365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-7511","authenticated-orcid":false,"given":"Marialuisa","family":"Framarino-dei-Malatesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sammartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"3772_CR1","doi-asserted-by":"publisher","unstructured":"Albright CM, Wenstrom KD. Malignancies in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015; doi: 10.1016\/j.bpobgyn.2015.10.004 .","DOI":"10.1016\/j.bpobgyn.2015.10.004"},{"key":"3772_CR2","unstructured":"Fecondit\u00e0 in ripresa e calendario riproduttivo posticipato. National Institute of Statistics 2013. https:\/\/www.istat.it\/it\/files\/2014\/03\/Noi-Italia-2014.pdf . Accessed 31 Mar 2016."},{"key":"3772_CR3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.breast.2012.05.002","volume":"21","author":"AS Genin","year":"2012","unstructured":"Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R. Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast. 2012;21:550\u20135.","journal-title":"Breast"},{"key":"3772_CR4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.diii.2013.12.021","volume":"95","author":"A Langer","year":"2014","unstructured":"Langer A, Mohallem M, Stevens D, Rouzier R, Lerebours F, Ch\u00e9rel P. A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome. Diagn Interv Imaging. 2014;95:435\u201341.","journal-title":"Diagn Interv Imaging"},{"key":"3772_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.hoc.2011.01.001","volume":"25","author":"U Abadi","year":"2011","unstructured":"Abadi U, Koren G, Lishner M. Leukemia and lymphoma in pregnancy. Hematol Oncol Clin North Am. 2011;25:277\u201391.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"3772_CR6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185\u2013229. Review","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3772_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pharmthera.2011.07.006. Epub 2011 Aug 3. Review.","volume":"133","author":"R Kizek","year":"2012","unstructured":"Kizek R, Adam V, Hrabeta J, Eckschlager T, Smutny S, Burda JV, et al. Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances. Pharmacol Ther. 2012;133(1):26\u201339. doi: 10.1016\/j.pharmthera.2011.07.006 . Epub 2011 Aug 3. Review.","journal-title":"Pharmacol Ther"},{"key":"3772_CR8","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","volume":"67","author":"YL Lyu","year":"2007","unstructured":"Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, et al. Topoisomerase 11beta mediated DNA double-strand breaks implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res. 2007;67:8839\u201346.","journal-title":"Cancer Res"},{"issue":"13","key":"3772_CR9","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.lfs.2004.05.040","volume":"76","author":"H Mizutani","year":"2005","unstructured":"Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 2005;76(13):1439\u201353. Epub 2005 Jan 20","journal-title":"Life Sci"},{"issue":"3","key":"3772_CR10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/mol.107.041335","volume":"73","author":"X Xu","year":"2008","unstructured":"Xu X, Sutak R, Richardson DR. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking. Mol Pharmacol. 2008;73(3):833\u201344. Epub 2007 Nov 20","journal-title":"Mol Pharmacol"},{"issue":"2","key":"3772_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617\u201330. doi: 10.1172\/JCI72931 . Epub 2014 Jan 2","journal-title":"J Clin Invest"},{"key":"3772_CR12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ijcard.2014.07.149","volume":"176","author":"S Patan\u00e8","year":"2014","unstructured":"Patan\u00e8 S. Cardiotoxicity: anthracyclines and long-term cancer survivors. Int J Cardiol. 2014;176:1326\u20138.","journal-title":"Int J Cardiol"},{"key":"3772_CR13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1378\/chest.14-0460","volume":"146","author":"D Nikitovic","year":"2014","unstructured":"Nikitovic D, Juranek I, Wilks MF, Tzardi M, Tsatsakis A, Tzanakakis GN. Anthracycline-dependent cardiotoxicity and extracellular matrix remodeling. Chest. 2014;146:1123\u201330.","journal-title":"Chest"},{"issue":"3","key":"3772_CR14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0014-5793(00)01747-6","volume":"476","author":"H Sauer","year":"2000","unstructured":"Sauer H, Rahimi G, Hescheler J, Wartenberg M. Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett. 2000;476(3):218\u201323.","journal-title":"FEBS Lett"},{"key":"3772_CR15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2002.036509","volume":"548","author":"S Siedner","year":"2003","unstructured":"Siedner S, Kr\u00fcger M, Schroeter M, Metzler D, Roell W, Fleischmann BK, et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol. 2003;548:493\u2013505.","journal-title":"J Physiol"},{"key":"3772_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","volume":"43","author":"S Mr","year":"2004","unstructured":"Mr S, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43:487\u2013514.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"3772_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/17425255.3.3.331","volume":"3","author":"P Myllynen","year":"2007","unstructured":"Myllynen P, Pasanen M, V\u00e4h\u00e4kangas K. The fate and effects of xenobiotics in human placenta. Expert Opin Drug Metab Toxicol. 2007;3(3):331\u201346.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3772_CR18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","volume":"20","author":"F Staud","year":"2012","unstructured":"Staud F, Cerveny L, Ceckova M. Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target. 2012;20:736\u201363.","journal-title":"J Drug Target"},{"issue":"5","key":"3772_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/138920111795470877","volume":"12","author":"T Eskholi","year":"2011","unstructured":"Eskholi T, Sheiner E, Ben-Zvi Z, Holcberg G. Drug transport across the placenta. Curr Pharm Biotechnol. 2011;12(5):707\u201314. Review","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"3772_CR20","first-page":"827","volume":"9","author":"H Burger","year":"2003","unstructured":"Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res. 2003;9(2):827\u201336.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3772_CR21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","volume":"158","author":"K V\u00e4h\u00e4kangas","year":"2009","unstructured":"V\u00e4h\u00e4kangas K, Myllynen P. Drug transporters in the human blood-placental barrier. Br J Pharmacol. 2009;158(3):665\u201378. Epub 2009 Sep 25","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3772_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/biolre\/iox012.","volume":"96","author":"N Walker","year":"2017","unstructured":"Walker N, Filis P, Soffientini U, Bellingham M, O'Shaughnessy PJ, Fowler PA. Placental transporter localization and expression in the human: the importance of species, sex, and gestational age differences. Biol Reprod. 2017;96(4):733\u201342. doi: 10.1093\/biolre\/iox012 .","journal-title":"Biol Reprod"},{"key":"3772_CR23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11095-007-9432-z","volume":"25","author":"H Wang","year":"2008","unstructured":"Wang H, Unadkat JD, Mao Q. Hormonal regulation of BCRP expression in human placental BeWo cells. Pharm Res. 2008;25:444\u201352.","journal-title":"Pharm Res"},{"key":"3772_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","volume":"36","author":"ET Morgan","year":"2008","unstructured":"Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos. 2008;36:205\u201316.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"3772_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","volume":"33","author":"M Iqbal","year":"2012","unstructured":"Iqbal M, Audette MC, Petropoulos S, Gibb W, Matthews SG. Placental drug transporters and their role in fetal protection. Placenta. 2012;33(3):137\u201342. doi: 10.1016\/j.placenta.2012.01.008 . Epub 2012 Jan 20","journal-title":"Placenta"},{"issue":"4","key":"3772_CR26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z","volume":"35","author":"M De Lena","year":"1975","unstructured":"De Lena M, Brambilla C, Morabito A, Bonadonna G. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. Cancer. 1975;35(4):1108\u201315.","journal-title":"Cancer"},{"key":"3772_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(83)91614-8","volume":"1","author":"M D'Incalci","year":"1983","unstructured":"D'Incalci M, Broggini M, Buscaglia M, Pardi G. Transplacental passage of doxorubicin. Lancet. 1983;1:75.","journal-title":"Lancet"},{"key":"3772_CR28","first-page":"773","volume":"67","author":"GI Karp","year":"1983","unstructured":"Karp GI, von Oeyen P, Valone F, Khetarpal VK, Israel M, Mayer RJ, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983;67:773\u20137.","journal-title":"Cancer Treat Rep"},{"key":"3772_CR29","doi-asserted-by":"crossref","unstructured":"Barni S, Ardizzoia A, Zanetta G, Strocchi E, Lissoni P, Tancini G. Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report. Tumori 1992;78:349\u201350.","DOI":"10.1177\/030089169207800513"},{"issue":"5","key":"3772_CR30","first-page":"595","volume":"18","author":"P Grohard","year":"1989","unstructured":"Grohard P, Akbaraly JP, Saux MC, Gimenez S, Robert J, Brachet-Liermain A, et al. Transplacental passage of doxorubicin. J Gynecol Obstet Biol Reprod (Paris). 1989;18(5):595\u2013600.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"1","key":"3772_CR31","first-page":"67","volume":"24","author":"B Gaillard","year":"1995","unstructured":"Gaillard B, Leng JJ, Grellet J, Ducint D, Saux MC. Transplacental passage of epirubicin. J Gynecol Obstet Biol Reprod. 1995;24(1):67\u20138.","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"1","key":"3772_CR32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","volume":"15","author":"N German","year":"2004","unstructured":"German N, Goffinet F, Goldwasse R. Anthracyclines during pregnancy: embryo\u2013fetal outcome in 160 patients. Ann Oncol. 2004;15(1):146\u201350.","journal-title":"Ann Oncol"},{"issue":"1","key":"3772_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1933719110379650","volume":"18","author":"K Van Calsteren","year":"2011","unstructured":"Van Calsteren K, Verbesselt R, Van Bree R, Heyns L, de Bruijn E, de Hoon J, et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci. 2011;18(1):57\u201363. doi: 10.1177\/1933719110379650 . Epub 2010 Sep 8","journal-title":"Reprod Sci"},{"key":"3772_CR34","doi-asserted-by":"crossref","unstructured":"Gziri MM, Pokreisz P, De Voz R, Verbeken E, Debi\u00e8ve F, Mertens L , et al. Fetal rat hearts do not display acute cardiotoxicity in response to maternal doxorubicin treatment. J Pharmacol Exp Ther 2013;346:362\u2013369.","DOI":"10.1124\/jpet.113.205419"},{"issue":"3","key":"3772_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Beijnen J, Devlieger R, De Catte L, Chai DC, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010;119(3):594\u2013600. doi: 10.1016\/j.ygyno.2010.08.019 . Epub 2010 Sep 17","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3772_CR36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1166\/jbn.2009.1021","volume":"5","author":"P Ma","year":"2009","unstructured":"Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, et al. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol. 2009;5(2):151\u201361.","journal-title":"J Biomed Nanotechnol"},{"key":"3772_CR37","doi-asserted-by":"publisher","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117\u201334. doi: 10.1016\/j.jconrel.2012.03.020 . Epub 2012 Mar 29. Review","DOI":"10.1016\/j.jconrel.2012.03.020"},{"issue":"2","key":"3772_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.toxlet.2015.09.011","volume":"239","author":"SK Soininen","year":"2015","unstructured":"Soininen SK, Repo JK, Karttunen V, Auriola S, V\u00e4h\u00e4kangas KH, Ruponen M. Human placental cell and tissue uptake of doxorubicin and its liposomal formulations. Toxicol Lett. 2015;239(2):108\u201314. doi: 10.1016\/j.toxlet.2015.09.011 . Epub 2015 Sep 14","journal-title":"Toxicol Lett"},{"issue":"35","key":"3772_CR39","doi-asserted-by":"publisher","first-page":"24314","DOI":"10.1074\/jbc.M114.570937","volume":"289","author":"B Lin","year":"2014","unstructured":"Lin B, Gupta D, Heinen CD. Human pluripotent stem cells have a novel mismatch repair-dependent damage response. J Biol Chem. 2014;289(35):24314\u201324. doi: 10.1074\/jbc.M114.570937 . Epub 2014 Jul 10","journal-title":"J Biol Chem"},{"issue":"5","key":"3772_CR40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","volume":"5","author":"E Cardonick","year":"2004","unstructured":"Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283\u201391. Review","journal-title":"Lancet Oncol."},{"key":"3772_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000317264","volume":"71","author":"M Leyder","year":"2011","unstructured":"Leyder M, Laubach M, Breugelmans M, Keymolen K, De Greve J, Foulon W. Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy. Gynecol Obstet Investig. 2011;71:141\u20134.","journal-title":"Gynecol Obstet Investig"},{"issue":"9","key":"3772_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1517\/17425255.2015.1055247","volume":"11","author":"DJ Bell","year":"2015","unstructured":"Bell DJ, Kerr DJ. Pharmacokinetic considerations in the use of anticancer drugs during pregnancy: challenges and new developments. Expert Opin Drug Metab Toxicol. 2015;11(9):1341\u20134. doi: 10.1517\/17425255.2015.1055247 . Epub 2015 Jun 22","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3772_CR43","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/annonc\/mdu140","volume":"25","author":"JGC Van Hasselt","year":"2014","unstructured":"Van Hasselt JGC, van Calsteren K, Heyns L, Han S, Mhallem Gziri M, Schellens JH, Beijnen JH, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol. 2014;25:2059\u201365.","journal-title":"Ann Oncol"},{"issue":"4","key":"3772_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00280-014-2406-z","volume":"73","author":"RJ Ryu","year":"2014","unstructured":"Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, et al. Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemother Pharmacol. 2014;73(4):789\u201397. doi: 10.1007\/s00280-014-2406-z . Epub 2014 Feb 15","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3772_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1060028014552516","volume":"49","author":"A Chang","year":"2015","unstructured":"Chang A, Patel S. Treatment of acute myeloid leukemia during pregnancy. Ann Pharmacother. 2015;49(1):48\u201368. doi: 10.1177\/1060028014552516 . Epub 2014 Sep 25","journal-title":"Ann Pharmacother"},{"issue":"8","key":"3772_CR46","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1592\/phco.2005.25.8.1134","volume":"25","author":"DM Niedermeier","year":"2005","unstructured":"Niedermeier DM, Frei-Lahr DA, Hall PD. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy. 2005;25(8):1134\u201340.","journal-title":"Pharmacotherapy"},{"key":"3772_CR47","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2266::AID-CNCR14>3.0.CO;2-7","volume":"86","author":"PL Giacalone","year":"1999","unstructured":"Giacalone PL, Laffargue F, B\u00e9nos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer. 1999;86:2266\u201372.","journal-title":"Cancer"},{"key":"3772_CR48","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1590\/S0100-879X2001001200007","volume":"34","author":"RM Peres","year":"2001","unstructured":"Peres RM, Sanseverino MT, Guimar\u00e3es JL, Coser V, Giuliani L, Moreira RK, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res. 2001;34:1551\u20139.","journal-title":"Braz J Med Biol Res"},{"issue":"9","key":"3772_CR49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1470-2045(12)70261-9","volume":"13","author":"S Loibl","year":"2012","unstructured":"Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887\u201396. doi: 10.1016\/S1470-2045(12)70261-9 . Epub 2012 Aug 16","journal-title":"Lancet Oncol."},{"key":"3772_CR50","unstructured":"Pregnancy and Breast Cancer. Royal College of Obstetricians and Gynaecologists. https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg12\/ ."},{"issue":"8","key":"3772_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jamaoncol.2015.2413","volume":"1","author":"S Loibl","year":"2015","unstructured":"Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer Care for Pregnant Patients. JAMA Oncol. 2015;1(8):1145\u201353. doi: 10.1001\/jamaoncol.2015.2413 .","journal-title":"JAMA Oncol"},{"key":"3772_CR52","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1200\/JCO.1999.17.3.855","volume":"17","author":"DL Berry","year":"1999","unstructured":"Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17:855\u201361.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3772_CR53","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","volume":"107","author":"KM Hahn","year":"2006","unstructured":"Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez Q, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107(6):1219\u201326.","journal-title":"Cancer"},{"key":"3772_CR54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PPO.0b013e3181ce46f9","volume":"16","author":"E Cardonick","year":"2010","unstructured":"Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16:76\u201382.","journal-title":"Cancer J"},{"key":"3772_CR55","doi-asserted-by":"crossref","unstructured":"Azim Jr, H.A., Peccatori, F.A., Scarfone, G., Acaia, B., Rossi, P., Cascio, R. et al. (2008) Anthracyclines for gestational breast cancer: course and outcome of pregnancy. Ann Oncol. 19: 1511 1512.","DOI":"10.1093\/annonc\/mdn396"},{"key":"3772_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1037\/0278-6133.27.1.43","volume":"27","author":"LM Glynn","year":"2008","unstructured":"Glynn LM, Schetter CD, Hobel CJ, Sandman CA. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol. 2008;27:43\u201351.","journal-title":"Health Psychol"},{"key":"3772_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejogrb.2013.11.017","volume":"173","author":"M Framarino-Dei-Malatesta","year":"2014","unstructured":"Framarino-Dei-Malatesta M, Piccioni MG, Brunelli R, Iannini I, Cascialli G, Sammartino P. Breast cancer during pregnancy: a retrospective study on obstetrical problems and survival. J Obstet Gynecol Reprod Biol. 2014;173:48\u201352. doi: 10.1016\/j.ejogrb.2013.11.017 . Epub 2013 Nov 28","journal-title":"J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"3772_CR58","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1634\/theoncologist.2014-0500","volume":"20","author":"JM Serrano","year":"2015","unstructured":"Serrano JM, Gonz\u00e1lez I, Del Castillo S, Mu\u00f1iz J, Morales LJ, Moreno F, et al. Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors. Oncologist. 2015;20(8):864\u201372. https:\/\/doi.org\/10.1634\/theoncologist.2014-0500 . Epub 2015 Jul 16","journal-title":"Oncologist"},{"key":"3772_CR59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1067\/mob.2000.105964","volume":"183","author":"C Achtari","year":"2000","unstructured":"Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol. 2000;183:511\u20132.","journal-title":"Am J Obstet Gynecol"},{"key":"3772_CR60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000243556","volume":"32","author":"AK Baumg\u00e4rtner","year":"2009","unstructured":"Baumg\u00e4rtner AK, Oberhoffer R, Jacobs VR, Ostermayer E, Menzel H, Voigt M, et al. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie. 2009;32:40\u20133.","journal-title":"Onkologie"},{"key":"3772_CR61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1525-1438.2002.01128.x","volume":"12","author":"BL Siu","year":"2002","unstructured":"Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer. 2002;12:399\u2013402.","journal-title":"Int J Gynecol Cancer"},{"key":"3772_CR62","doi-asserted-by":"crossref","unstructured":"Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer. 1988:435\u201340.","DOI":"10.1002\/1097-0142(19880201)61:3<435::AID-CNCR2820610305>3.0.CO;2-F"},{"key":"3772_CR63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1469-0705.2001.00373.x","volume":"18","author":"M Meyer-Wittkopf","year":"2001","unstructured":"Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol. 2001;18:62\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3772_CR64","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/AOG.0b013e31826c32d9","volume":"120","author":"E Cardonick","year":"2012","unstructured":"Cardonick E, Gylmandiar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol. 2012;120:1267\u201372.","journal-title":"Obstet Gynecol"},{"key":"3772_CR65","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1200\/JCO.2006.06.1382","volume":"24","author":"K Van Calsteren","year":"2006","unstructured":"Van Calsteren K, Berteloot P, Hanssens M, Vergote I, Amant F, Ganame J, et al. In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. J Clin Oncol. 2006;24:e16\u20137.","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"3772_CR66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10428199509054772","volume":"20","author":"F Goldwasser","year":"1995","unstructured":"Goldwasser F, Pico JL, Cerrina J, Fernandez H, Pons JC, Cosset JM, et al. Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient. Leuk Lymphoma. 1995;20(1\u20132):173\u20136.","journal-title":"Leuk Lymphoma"},{"key":"3772_CR67","first-page":"5225","volume":"23","author":"A Gadducci","year":"2003","unstructured":"Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 2003;23:5225\u20139.","journal-title":"Anticancer Res"},{"key":"3772_CR68","first-page":"261","volume":"25","author":"PV Ginopoulos","year":"2004","unstructured":"Ginopoulos PV, Michail GD, Kourounis GS. Pregnancy associated breast cancer: a case report. Eur J Gynaecol Oncol. 2004;25:261\u20133.","journal-title":"Eur J Gynaecol Oncol"},{"key":"3772_CR69","first-page":"1705","volume":"27","author":"B Bodner-Adler","year":"2007","unstructured":"Bodner-Adler B, Bodner K, Zeisler H. Breast cancer diagnosed during pregnancy. Anticancer Res. 2007;27:1705\u20137.","journal-title":"Anticancer Res"},{"key":"3772_CR70","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-008-0159-2","volume":"115","author":"FA Peccatori","year":"2009","unstructured":"Peccatori FA, Azim HA Jr, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat. 2009;115:591\u20134.","journal-title":"Breast Cancer Res Treat"},{"key":"3772_CR71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/14767058.2011.557107","volume":"25","author":"E Parodi","year":"2012","unstructured":"Parodi E, Alluto A, Moggio G, Liberale V, Frigerio M, Sismondi P. Transient ventricular hypocinesia after in utero anthracyclines exposure: a case report and review of the literature. J Matern Fetal Neonatal Med. 2012;25:189\u201392.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3772_CR72","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1186\/s12885-015-1976-4","volume":"15","author":"M Framarino-dei-Malatesta","year":"2015","unstructured":"Framarino-dei-Malatesta M, Perrone G, Giancotti A, Ventriglia F, Derme M, Iannini I, et al. Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literature. BMC Cancer. 2015;15:951. doi: 10.1186\/s12885-015-1976-4 .","journal-title":"BMC Cancer"},{"issue":"9","key":"3772_CR73","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.placenta.2010.06.014","volume":"31","author":"S Petropoulos","year":"2010","unstructured":"Petropoulos S, Gibb W, Matthews SG. Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse. Placenta. 2010;31(9):803\u201310. doi: 10.1016\/j.placenta.2010.06.014 . Epub 2010 Jul 23","journal-title":"Placenta"},{"issue":"12","key":"3772_CR74","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1600-0412.2012.01524.x","volume":"91","author":"MM Gziri","year":"2012","unstructured":"Gziri MM, Debi\u00e8ve F, DE Catte L, Mertens L, Barrea C, Van Calsteren K, et al. Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function. Acta Obstet Gynecol Scand. 2012;91(12):1465\u20138. doi: 10.1111\/j.1600-0412.2012.01524.x . Epub 2012 Nov 1","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"3772_CR75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdj053","volume":"17","author":"A Avil\u00e9s","year":"2006","unstructured":"Avil\u00e9s A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006;17(2):286\u20138. Epub 2005 Nov 4","journal-title":"Ann Oncol"},{"issue":"1","key":"3772_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clml.2015.09.009","volume":"16","author":"A Avil\u00e8s","year":"2016","unstructured":"Avil\u00e8s A, Nambo MJ, Huerta-Guzm\u00e0n J, Neri N, Cleto S. Speckle-tracking echocardiography to detect cardiac toxicity in children who received anthracyclines during pregnancy. Clin Lymphoma Myeloma Leuk. 2016;16(1):1\u20134.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3772_CR77","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","volume":"13","author":"F Amant","year":"2012","unstructured":"Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13:256\u201364.","journal-title":"Lancet Oncol"},{"key":"3772_CR78","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","volume":"373","author":"F Amant","year":"2015","unstructured":"Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, et al. International network on cancer, infertility, and pregnancy (INCIP). Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015;373:1824\u201334. doi: 10.1056\/NEJMoa1508913 . Epub 2015 Sep 28.","journal-title":"N Engl J Med"},{"issue":"7501","key":"3772_CR79","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature13324","volume":"509","author":"A Ben-Zvi","year":"2014","unstructured":"Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, Gu C. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509(7501):507\u201311. doi: 10.1038\/nature13324 . Epub 2014 May 14","journal-title":"Nature"},{"key":"3772_CR80","doi-asserted-by":"publisher","unstructured":"Strazielle N, Ghersi-Egea JF. Efflux transporters in blood-brain interfaces of the developing brain. Front Neurosci. 2015;9:21. doi: 10.3389\/fnins.2015.00021 . eCollection 2015. Review","DOI":"10.3389\/fnins.2015.00021"},{"issue":"3","key":"3772_CR81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","volume":"2","author":"A Avil\u00e8s","year":"2001","unstructured":"Avil\u00e8s A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2(3):173\u20137.","journal-title":"Clin Lymphoma"},{"issue":"5","key":"3772_CR82","doi-asserted-by":"publisher","first-page":"658.e1","DOI":"10.1016\/j.ajog.2014.11.032","volume":"212","author":"EH Cardonick","year":"2015","unstructured":"Cardonick EH, Gringlas MB, Hunter K, Greenspan J. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. Am J Obstet Gynecol. 2015;212(5):658.e1\u20138. doi: 10.1016\/j.ajog.2014.11.032 . Epub 2014 Nov 27","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"3772_CR83","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/jog.12389","volume":"40","author":"Y Li","year":"2014","unstructured":"Li Y, Fang J, Zhou K, Wang C, Mu D, Hua Y. Evaluation of oxidative stress in placenta of fetal cardiac dysfunction rat model and antioxidant defenses of maternal vitamin C supplementation with the impacts on P-glycoprotein. J Obstet Gynaecol Res. 2014;40(6):1632\u201342. doi: 10.1111\/jog.12389 .","journal-title":"J Obstet Gynaecol Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3772-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T07:11:17Z","timestamp":1570345877000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3772-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3772"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3772-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"777"}}